glp 1 receptor agonists and kidney protection Role of GLP1 RA in Diabetic disease (as per ADA 2026 guidelines) Unlocking Cardio-Renal Protection: Breakthrough with

A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.

We take a personalized, medically guided approach to ensure safe and effective results.

With the increasing use of Glucagon-Like Peptide-1 Receptor (GLP-1R) agonists for diabetes management and weight loss, their implications in perioperative care have gained attention

However, most (59%) of same those employers say their cost for the drugs has exceeded expectations

In response to shortages, the FDA allowed use of compounded GLP-1 drugs. What are “compounded drugs? Most prescription medications are approved by the FDA and manufactured by drug companies.Compoundeddrugs are made by licensed pharmacists or physicians who […]

If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point